Cabaletta Bio, Inc. (CABA)
NASDAQ: CABA · Real-Time Price · USD
2.765
-0.210 (-7.06%)
At close: Jul 13, 2026, 4:00 PM EDT
2.760
-0.005 (-0.18%)
After-hours: Jul 13, 2026, 7:56 PM EDT
Cabaletta Bio Market Cap
Cabaletta Bio has a market cap or net worth of $450.85 million as of July 13, 2026. Its market cap has increased by 194.86% in one year.
Market Cap
450.85M
Enterprise Value
360.66M
1-Year Change
194.86%
Ranking
Category
Stock Price
$2.77
Market Cap Chart
Since October 25, 2019, Cabaletta Bio's market cap has increased from $235.53M to $450.85M, an increase of 91.42%. That is a compound annual growth rate of 10.14%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 13, 2026 | 450.85M | 113.85% |
| Dec 31, 2025 | 210.82M | 90.01% |
| Dec 31, 2024 | 110.95M | -88.59% |
| Dec 29, 2023 | 972.68M | 260.85% |
| Dec 30, 2022 | 269.55M | 151.03% |
| Dec 31, 2021 | 107.38M | -64.23% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Oct 25, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Prothena Corporation | 464.90M |
| Sutro Biopharma | 464.64M |
| Ovid Therapeutics | 457.27M |
| Verastem | 451.67M |
| Benitec Biopharma | 445.06M |
| Evommune | 443.39M |
| Prelude Therapeutics | 441.84M |
| Sagimet Biosciences | 440.29M |